MarketInOut Stock Screener Log In | Sign Up
 

Sight Sciences Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Sight Sciences Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization505.43 mln
Float35.57 mln
Earnings Date11/04/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.28
Borderline

1-Year Forecast

10.17
Modest upside

Relative Strength

75 / 100
Strongly outperforming

Debt / Equity

0.79
Moderate leverage

Pre-Tax Margin

-36%
Deeply loss-making

Business Description

Sight Sciences is a US-based medical device company dedicated to treating common eye conditions through both surgical and non-surgical solutions. Its core products include the OMNI system for glaucoma, which reduces eye pressure without leaving an implant behind, and the TearCare system, which targets dry eye by clearing blocked glands that are responsible for healthy tear production. The company sells its products to hospitals, eye clinics, and eye care professionals across the country.

Key Fundamentals

EPS-0.56
ROE-48.78
RPS1.56
ROIC-158
ROA-26.19
Interest Cover-10.65
EBITDA, mln-24.23
EV / EBITDA-19.86
EV / EBIT-19.53
Revenue, mln83.38
EV / Revenue5.77

Quote Details

Last 8.99
Change -0.1 (-1.1%)
Open 9.08
Volume 340,863
Turnover 3,064,358
Average Volume 346,108

Financial Ratios

Pre-Tax Profit Margin-36
Leverage Ratio1.98
Current Ratio4.95
Price / Book9.73
Price / Tangible Book9.73
Debt / Equity0.79
Price / Sales6.04

Financial Strength

Altman Z-Score1.52
Piotroski F-Score 5 / 9
Beneish M-Score-2.28
1-Year Target Price10.17
Short Ratio5.66
Short % of Float3.53

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.57% 93 / 100   
1 Month 3.57% 86 / 100   
2 Months 78.37% 99 / 100   
6 Months 106% 98 / 100   
1 Year 75.24% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog